Reaction Details |
| Report a problem with these data |
Target | Mu-type opioid receptor |
---|
Ligand | BDBM114627 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Late stage Counterscreen for the probe development effort to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) |
---|
EC50 | 92470±n/a nM |
---|
Citation | PubChem, PC Late stage Counterscreen for the probe development effort to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Mu-type opioid receptor |
---|
Name: | Mu-type opioid receptor |
Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 44789.51 |
Organism: | Homo sapiens (Human) |
Description: | P35372 |
Residue: | 400 |
Sequence: | MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCP
PTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALAT
STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDF
RTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFI
FAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHI
YVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNI
EQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
|
|
|
BDBM114627 |
---|
n/a |
---|
Name | BDBM114627 |
Synonyms: | 1-[(5-methyl-2-thienyl)methyl]-4-(2-pyridyl)piperazine | 1-[(5-methyl-2-thiophenyl)methyl]-4-(2-pyridinyl)piperazine | 1-[(5-methylthiophen-2-yl)methyl]-4-pyridin-2-yl-piperazine | 1-[(5-methylthiophen-2-yl)methyl]-4-pyridin-2-ylpiperazine | SR-01000209113 | SR-01000209113-3 | cid_783472 |
Type | Small organic molecule |
Emp. Form. | C15H19N3S |
Mol. Mass. | 273.396 |
SMILES | Cc1ccc(CN2CCN(CC2)c2ccccn2)s1 |
Structure |
|